{"id":35972,"date":"2025-10-14T21:48:23","date_gmt":"2025-10-14T14:48:23","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=35972"},"modified":"2025-10-14T21:48:23","modified_gmt":"2025-10-14T14:48:23","slug":"asia-university-partners-with-nucleicai-to-build-a-sovereign-ai-life-science-data-platform","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=35972","title":{"rendered":"Asia University Partners with NucleicAI to Build a Sovereign AI Life Science Data Platform"},"content":{"rendered":"

TAICHUNG<\/span>, Oct. 14, 2025<\/span><\/span> \/PRNewswire\/ — Asia<\/span> University<\/a> will partner with NucleicAI LLC<\/a>, a next-generation platform and data company specializing in AI-driven genomics, precision medicine, and health intelligence, to build a Sovereign AI Life Science Data Platform<\/b>\u00a0in Taiwan<\/span><\/b>.<\/b>\u00a0The platform will be hosted in-country, supporting secure data sharing, advanced analytics, and research collaboration while preserving data sovereignty.<\/p>\n

\n

\"Asia <\/a>
Asia University President Jeffrey J.P. Tsai (left) and Professor Alireza Haghighi (right), Co-Founder of NucleicAI and Chief Executive of Harvard Medical School International Center for Genetic Disease, signed an MoU to jointly develop a Life Science Data Platform.<\/span><\/p>\n<\/div>\n

The signing of the Memorandum of Understanding took place at the IEEE International Conference on AI \u00d7 Medicine, Health, and Care<\/i> in Taichung, featuring a keynote by Prof. Alireza Haghighi<\/span><\/b> and remarks by Asia University President, Prof. Jeffrey<\/b>\u00a0J.P.<\/b>\u00a0Tsai<\/b>.<\/p>\n

“This partnership with NucleicAI represents a significant step toward building the\u00a0next-generation health data ecosystem,” said President Jeffrey<\/b>\u00a0J.P.<\/b>\u00a0Tsai<\/b>. “By integrating global technology with local excellence, we’re accelerating discovery in alignment with Asia<\/span> University’s strategic vision to lead in biomedical innovation.”<\/p>\n

“Taiwan’s<\/span> biomedical and academic ecosystem is uniquely positioned to lead the next wave of health innovation. This collaboration builds a comprehensive data infrastructure to accelerate predictive, preventive, and precision medicine, while enabling novel drug discovery,” said Prof. Alireza Haghighi<\/span><\/b>, Co-Founder of NucleicAI and Chief Executive of Harvard Medical School International Center for Genetic Disease.<\/p>\n

“This is the kind of ambitious, forward-thinking collaboration that transforms how we use data to advance human health and longevity,” added Prof. David Sinclair<\/span><\/b>, Harvard Medical School Professor and Co-Founder of NucleicAI. “We are thrilled to partner with leading institutions in Taiwan<\/span> to demonstrate what’s possible when AI meets life science at scale.”<\/p>\n

This collaboration also includes research in genomics, AI-driven analytics, and human longevity while emphasizing data sovereignty and best practices in data governance.<\/p>\n

Asia<\/span> University will migrate its life science and healthcare data to the platform, enabling robust collaboration, privacy-preserving analytics, AI-powered insights, and broader global partnerships, particularly with leading industry stakeholders. It will also collaborate with other top institutions across Taiwan<\/span> to support the secure migration of their data, further strengthening national collaboration and driving innovation.<\/p>\n

About Asia<\/span> University<\/b>
Asia<\/span> University (Taichung, Taiwan<\/span>) is an internationally ranked university recognized for excellence in AI, biomedical science, health management, digital innovation, and sustainability.<\/p>\n

About NucleicAI<\/b>
NucleicAI LLC (Boston, Massachusetts<\/span>) is a next-generation platform and data company integrating AI and multi-omics to power precision medicine, human longevity, and health intelligence.<\/p>\n

For more information, visit:<\/b>\u00a0https:\/\/web.asia.edu.tw\/<\/a> and https:\/\/www.nucleicai.com\/<\/a><\/p>","protected":false},"excerpt":{"rendered":"

<\/p>\n

TAICHUNG<\/span>, Oct. 14, 2025<\/span><\/span> \/PRNewswire\/ — Asia<\/span> University<\/a> will partner with NucleicAI LLC<\/a>, a next-generation platform and data company specializing in AI-driven genomics, precision medicine, and health intelligence, to build a Sovereign AI Life Science Data Platform<\/b>\u00a0in Taiwan<\/span><\/b>.<\/b>\u00a0The platform will be hosted in-country, supporting secure data sharing, advanced analytics, and research collaboration while preserving data sovereignty.<\/p>\n

\n

\"Asia <\/a>
Asia University President Jeffrey J.P. Tsai (left) and Professor Alireza Haghighi (right), Co-Founder of NucleicAI and Chief Executive of Harvard Medical School International Center for Genetic Disease, signed an MoU to jointly develop a Life Science Data Platform.<\/span><\/p>\n<\/div>\n

The signing of the Memorandum of Understanding took place at the IEEE International Conference on AI \u00d7 Medicine, Health, and Care<\/i> in Taichung, featuring a keynote by Prof. Alireza Haghighi<\/span><\/b> and remarks by Asia University President, Prof. Jeffrey<\/b>\u00a0J.P.<\/b>\u00a0Tsai<\/b>.<\/p>\n

“This partnership with NucleicAI represents a significant step toward building the\u00a0next-generation health data ecosystem,” said President Jeffrey<\/b>\u00a0J.P.<\/b>\u00a0Tsai<\/b>. “By integrating global technology with local excellence, we’re accelerating discovery in alignment with Asia<\/span> University’s strategic vision to lead in biomedical innovation.”<\/p>\n

“Taiwan’s<\/span> biomedical and academic ecosystem is uniquely positioned to lead the next wave of health innovation. This collaboration builds a comprehensive data infrastructure to accelerate predictive, preventive, and precision medicine, while enabling novel drug discovery,” said Prof. Alireza Haghighi<\/span><\/b>, Co-Founder of NucleicAI and Chief Executive of Harvard Medical School International Center for Genetic Disease.<\/p>\n

“This is the kind of ambitious, forward-thinking collaboration that transforms how we use data to advance human health and longevity,” added Prof. David Sinclair<\/span><\/b>, Harvard Medical School Professor and Co-Founder of NucleicAI. “We are thrilled to partner with leading institutions in Taiwan<\/span> to demonstrate what’s possible when AI meets life science at scale.”<\/p>\n

This collaboration also includes research in genomics, AI-driven analytics, and human longevity while emphasizing data sovereignty and best practices in data governance.<\/p>\n

Asia<\/span> University will migrate its life science and healthcare data to the platform, enabling robust collaboration, privacy-preserving analytics, AI-powered insights, and broader global partnerships, particularly with leading industry stakeholders. It will also collaborate with other top institutions across Taiwan<\/span> to support the secure migration of their data, further strengthening national collaboration and driving innovation.<\/p>\n

About Asia<\/span> University<\/b>
Asia<\/span> University (Taichung, Taiwan<\/span>) is an internationally ranked university recognized for excellence in AI, biomedical science, health management, digital innovation, and sustainability.<\/p>\n

About NucleicAI<\/b>
NucleicAI LLC (Boston, Massachusetts<\/span>) is a next-generation platform and data company integrating AI and multi-omics to power precision medicine, human longevity, and health intelligence.<\/p>\n

For more information, visit:<\/b>\u00a0https:\/\/web.asia.edu.tw\/<\/a> and https:\/\/www.nucleicai.com\/<\/a><\/p>\n

<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[5,7],"tags":[],"class_list":["post-35972","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cision-pr-newswire","category-cision-pr-newswire-en"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/35972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=35972"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/35972\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=35972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=35972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=35972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}